Barclays lowered the firm’s price target on Cemex (CX) to $8 from $9 and keeps an Overweight rating on the shares. The company reported soft Q4 results with operating EBITDA coming in at $747M, well below Barclays’ estimate of $802M, the analyst tells investors in a research note. However, the firm believes most of the negative is priced into the shares.
Don't Miss out on Research Tools:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter